Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin and dapagliflozin in liver transplantation
IRCT20170609034406N14Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of empagliflozin and dapagliflozin in decompensated cirrhosis, sponsored by Tabriz University of Medical Sciences. Started May 2025; status: completed.
02
Drugs
empagliflozindapagliflozin
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on IRCT20170609034406N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170609034406N14.